Gut Oxygen Therapy for Ischemic-Hypoxic Bowel Disease

Recruiting N/A Interventional Study
Chronic Ischemic-Hypoxic Enteropathy
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
100 (estimated)
Sponsor
The Second Hospital of Nanjing Medical University · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
This single-center, double-blind, randomized, intra-individual crossover controlled study aims to investigate the efficacy and safety of intestinal oxygen therapy via a deep intestinal catheter as a targeted route for intestinal oxygen delivery in the treatment of ischemic-hypoxic enteropathy, and simultaneously to explore and verify the chronobiological differences. Data have been obtained from t…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Definite diagnosis of chronic heart failure or obstructive sleep apnea (OSA) with chronic hypoxia; * Comorbid intestinal dysmotility (abdominal distension, constipation, diarrhea, or abdominal pain); * Disease duration ≥1 month with poor response to conventional treatment; * T…
Contacts

Faming Zhang, PhD

086-25-58509883

fzhang@njmu.edu.cn

CONTACT